Skip to main content
Top
Published in: Current Rheumatology Reports 1/2006

01-02-2006

New thoughts on the pathophysiology of osteoarthritis: One more step toward new therapeutic targets

Authors: Johanne Martel-Pelletier, PhD, Daniel Lajeunesse, PhD, Hassan Fahmi, PhD, Ginette Tardif, PhD, Jean-Pierre Pelletier, MD

Published in: Current Rheumatology Reports | Issue 1/2006

Login to get access
Metadata
Title
New thoughts on the pathophysiology of osteoarthritis: One more step toward new therapeutic targets
Authors
Johanne Martel-Pelletier, PhD
Daniel Lajeunesse, PhD
Hassan Fahmi, PhD
Ginette Tardif, PhD
Jean-Pierre Pelletier, MD
Publication date
01-02-2006
Publisher
Current Medicine Group
Published in
Current Rheumatology Reports / Issue 1/2006
Print ISSN: 1523-3774
Electronic ISSN: 1534-6307
DOI
https://doi.org/10.1007/s11926-006-0022-6

Other articles of this Issue 1/2006

Current Rheumatology Reports 1/2006 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine